Meds
Ended Awarded Last action
- Contract number
- 36C26223F0174
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $925,328
Award facts
- Contract value 100% obligated
- $925,328.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$30,982 | |
| Funding Only Action | $0 | |
| Supplemental Agreement for work within scope | $270,654 | |
| Original award | $685,657 |
About this award
The U.S. Department of Veterans Affairs (VA) awarded a $925,328.45 firm fixed price delivery order contract to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. The contract is for the delivery of PYLARIFY, a radiopharmaceutical diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. This delivery order is part of a larger Blanket Purchase Agreement (BPA) with the VA, valued at $5.5 million, which facilitates the ongoing procurement of PYLARIFY and other radiopharmaceuticals for cancer detection and treatment at VA medical facilities. The contract is not set aside and is awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). This award supports the VA's efforts to provide advanced diagnostic imaging capabilities for prostate cancer to veterans.
Quick answers
Who was awarded contract 36C26223F0174?
36C26223F0174 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on January 23, 2023.
How much is contract 36C26223F0174 worth?
The government has obligated $925,328 on 36C26223F0174.
Is contract 36C26223F0174 an order under another contract?
Yes. 36C26223F0174 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26223F0174 competed?
The extent of competition for 36C26223F0174 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award